Mid-Atlantic BioTherapeutics, Inc.

About Mid-Atlantic BioTherapeutics, Inc.

Mid-Atlantic BioTherapeutics (MABT), founded in 2011, aims to make a meaningful difference in the lives of patients, families, and communities worldwide by advancing cutting-edge therapies for challenging neurological and infectious diseases. MABT is committed to pushing scientific boundaries using biotechnology and AI to address unmet needs in treating hard-to-treat disorders, with a focus on neurodegenerative conditions like Alzheimer's, Parkinson's, and ALS.

Products & Services

Alzheimer's Treatment:Therapies targeting Alzheimer's disease, a chronic neurodegenerative disorder causing memory and cognitive decline.

ALS Treatment:Therapies for Amyotrophic Lateral Sclerosis (ALS), a progressive neurodegenerative disorder impacting voluntary muscle movement.

Infectious Disease Treatments and Vaccines:New treatments and vaccines for hard-to-treat infectious diseases like rabies, COVID, and influenza.

IMT504 Immunotherapy Platform:A proprietary technology platform for immunotherapy, notably the first to qualify for Orphan Drug Designation for Rabies.

Specialties

Neurodegenerative Disorders (Alzheimer's, Parkinson's, ALS) Infectious Diseases (Rabies, COVID, Influenza) Biotechnology AI-driven Drug Discovery and Development Immunotherapy (IMT504 Platform)

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Regulation D 506(c) Offering T: - FT: Regulation D 506(c) Offering	A: 5000000 MR: - FA: $5,000,000 FAN: 5000000	D: 2024-10-15 FD: 2024-10-15	-
2	RT: Equity Subscription Agreement T: - FT: Equity Subscription Agreement	A: 5000000 MR: - FA: USD 5 million FAN: 5000000	D: 2024-06-19 FD: 2024-06-19	1 investors

Regulation D 506(c) Offering Latest

2024-10-15

$5.0M

Equity Subscription Agreement 2024-06-19

$5.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Michael Goldblatt

Chief Executive Officer

J

Julian Chick

A

Andrew Katz

O.D.

D

David Horn

CEO & Founder

D

Dave Jobes

President & Co-Founder

J

Jean-Pierre Gagnon

Senior VP of Operations and Co-Founder

View 5 more team members with Pro

Unlock Full Team Directory

Recent News